For Elderly, Multiple Meds After Heart Attack Come at a Cost

For Elderly, Multiple Meds After Heart Attack Come at a Cost

Elderly nursing home patients prescribed a multitude of medications following a heart attack may live longer compared to those given just one drug, but it can come at a cost: It may negatively impact their quality of life.

Researchers examined claims data from nearly 4,800 nursing home residents, most of whom were white women with an average age of 84. The study looked at deaths, hospitalizations and decreased ability to manage daily activities after the residents were prescribed one of four kinds of medications after leaving the hospital following a heart attack. Those medications were beta blockers, blood thinners, blood pressure drugs and statins.

Results, published in Circulation: Cardiovascular Quality and Outcomes, showed that residents prescribed three or four medications after hospital discharge were less likely to die within 90 days compared with those prescribed just one medication. The death risk between those taking one or two medications did not differ.

Additional analysis found that, with the exception of blood thinners, greater medication use was associated with a 30% increase in functional decline.

“Since using more medications may interfere with older adults’ ability to do their daily activities, more medications should not be taken by older adults who wish to maintain their independence and daily functioning rather than live longer,” lead author Andrew R. Zullo, PharmD, PhD, an assistant professor at the Brown University School of Public Health, said in a statement. “Using more medications after a heart attack does not simply improve all health outcomes.”


Jonathan Block

Jonathan Block

Jonathan Block is an associate editor at BioCentury, which provides news and information about the biotechnology and pharmaceutical industries. Prior to joining BioCentury in 2019, Jonathan worked for MedShadow as content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Diabetes, Fertility Supplements, Nootropics

Diabetes, Fertility Supplements, Nootropics

Supplements are sold without review or approval of the FDA. They are not allowed to make specific health claims, but general ones, such as “improves well-being” and “boosts energy” are legal.  That leaves the door open for unscrupulous, or careless, manufacturers. The FDA also does not regulate the manufacturers recommended…

Vitamin E, the Source of Mystery Vaping Illness

Vitamin E, the Source of Mystery Vaping Illness

A “breakthrough” in the investigation of vaping illness and death, EVALI, has been announced by Federal health officials and the CDC (Centers for Disease Control).

  • Advertisement